PreDiagnose ApS: Financial statements 2024
CVR: 38562770
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PreDiagnose ApS (CVR 38562770) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 71,026 and a net result of DKK 60,353 compared with DKK 40,403 the year before. That is an increase of 34.1% compared with the year before. Equity in the 2024 report amounted to DKK 1,201,215. The solvency ratio was 79.9%.
- Gross Profit
- DKK 71,026
- Profit/Loss
- DKK 60,353
- Equity
- DKK 1,201,215
- Total Assets
- DKK 1,503,881
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 71 t. | 60 t. | 1.2 mio. | 0 |
| 2023 | - | 53 t. | 40 t. | 1.1 mio. | 1 |
| 2022 | - | 85 t. | -64 t. | 1.1 mio. | 1 |
| 2021 | - | 574 t. | 453 t. | 1.2 mio. | 3 |
| 2020 | - | 766 t. | 628 t. | 712 t. | 3 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PreDiagnose ApS has published its annual report for 2023. Gross profit came to DKK 52,969, and the net result was DKK 40,403.
About PreDiagnose ApS
PreDiagnose ApS is a Danish company of the type Anpartsselskab based in Karlslunde, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named PreDiagnose IVS. The management consists of Fatima Al-Zahraa Al Atraktchi. The company is owned by FZA ApS. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK 129,206 and a net result of DKK 2,564 compared with DKK 60,353 the year before. Equity in the 2025 report amounted to DKK 1,203,779.